2018
- Sysmex Launches Flow FISH Testing System for Research Applications That Utilizes Imaging FCM Technology to Automate FISH Testing
- Sysmex Receives Manufacturing and Marketing Approval to Use the OncoGuide™ NCC Oncopanel System in Cancer Genome Profiling
-
Sysmex Launches New Products in the Hemostasis Field: Automated Blood Coagulation Analyzers CN-6000 and CN-3000
-Making Testing Even More Efficient and of Higher Quality through Higher Levels of Productivity, Reliability, and Operability- -
With a View to New Value Creation, Sysmex Launches a Research Assay Service for HDL Function Measurement
-Aiming to Prevent Atherosclerosis-Related Diseases and Provide Treatment Opportunities- - Sysmex Wins the Encouragement Prize for the First Time in the 6th WICI Japan Award for Excellence in Integrated Reporting
-
Sysmex Launches Revohem FIX Chromogenic, a Blood Coagulation Factor IX Measurement Kit
-Japan’s First Coagulation Factor IX Measurement Kit Using Chromogenic Assay, Helping to Diagnose and Assist in the Treatment of Hemophilia B- -
Sysmex and MolecularMD Commence Global Partnership to Address the Challenges in Companion Diagnostics Development and Commercialization
-To Accelerate Precision Medicine Through Globally Proven Experience- -
Sysmex Launches Single Molecule Fluorescence Microscope HM-1000 for Research Use
-Supporting R&D Related to New Therapeutic Drugs and Diagnostic Methods with a Super-Resolution Fluorescence Microscope Having High Spatial Resolution- - Sysmex Wins Awards in 2018 Kinki Local Commendations for Innovations
- Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2019 (PDF：579KB)
- Announcement Regarding Differences between Actual and Forecast Figures for the Six Months Ended September 30, 2018, and Revision of Full-Year Financial Forecasts (PDF：62KB)
- Strengthening Our Global R&D Structure to Foster Early-Stage Innovation
-
RIKEN GENESIS to Perform Sequencing Analysis for Todai OncoPanel
-Supporting Launch of Advanced Medical Care “Cancer Gene Panel Testing” by the University of Tokyo- - Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Third Consecutive Year
- Announcement of Personnel Change (PDF：52KB)
-
Sysmex Launches New Product for the China Market in Its Automated Hematology Analyzer XS-Series
-Using a New Product Supply Scheme to Accelerate Business Expansion in China- -
Sysmex, Toppan Printing, and RIKEN GENESIS Commence Launch of Fully Automated System (Research Use Only) to Detect Gene Mutations in Cancer Tissue
-Streamlining the Gene Testing Processes to Standardize the Testing- -
Sysmex Partec’s CyFlow™ Counter System, a System to Test for CD4+ Lymphocytes, Receives WHO Prequalification
-Aiming to Help Improve the Quality of HIV Diagnosis and Treatment in Emerging Markets and Developing Countries- -
Sysmex America Opens “Center for Learning,” Expanding Training Facilities for Customers in North America
-Enhancing Its Service and Support to Further Increase Customer Satisfaction- -
Sysmex to Launch HISCL™ Presepsin Assay Kit for Sepsis Testing
-Contributes to early diagnosis of bacterial sepsis by promoting presepsin testing in conjunction with the HISCL™-Series- - Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2019 (PDF：626KB)
- Sysmex and JVCKENWOOD Jointly Establish Company to Use Micro and Nano-Fabrication Technology to Develop and Manufacture IVD Biodevices
- Sysmex Establishes Subsidiary in Egypt and Begins Conducting Direct Sales and Services
- Our Views and Policy regarding Investment Unit Reduction (PDF：31KB)
- Sysmex, the Foundation for Biomedical Research and Innovation at Kobe, and Kyoto University Begin Joint Research on Technologies for Diagnosing Immunological Diseases
-
Sysmex Launches New Products in Its System for the Testing of Cancer Lymph Node Metastasis Using the OSNA™ Method: Gene Amplification Detector RD-200 and LYNOAMP™ CK19
-Contributing to Standardization in the Testing of Cancer Lymph Node Metastasis by Shortening Testing Times and Augmenting Processing Capacity- - Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 (PDF：415KB)
- Sysmex Announces Changes from Financial Forecasts and Year-End Dividend (Commemorative Dividend) for the Fiscal Year Ended March 31, 2018 (PDF：87KB)
- Notice of the Booking of a Provision of Allowance for Doubtful Accounts (Non-Consolidated) Related to Loans to an Affiliated Company (PDF：40KB)
-
Sysmex Group Formulates New Long-Term Management Goals
Celebrating Our 50th Anniversary by Taking on New Challenges to Move to the Next Stage -
Sysmex Announces “Sysmex Eco-Vision 2025”
—To contribute to a sustainable society— -
Sysmex to Establish Bio-Diagnostic Reagent Center
Reinforcing Our Diagnostic Reagent Development and Production Function by Establishing a Location to Handle Integrated Development through Production and Distribution of Bio-Diagnostic Reagents - Sysmex Employee to Receive the “Medal with Purple Ribbon,” a Spring 2018 Medal of Honor
-
Sysmex to Launch JICA Project in the Republic of Ghana:
"Collaboration Program for Disseminating Automated Urinalysis Diagnosis Technology” -
Sysmex Obtains Certification under ISO Guide 34, the International Standard for the Competence of Reference Material Producers
-Initiatives toward Further Standardization and Quality Improvement of Clinical Testing- -
Sysmex Launches Caresphere,™ a New Network Solution
-Supporting the Intelligent Use of Information for the Healthcare of the Future, Where the Use of Information is Accelerating- - Sysmex and ImmuniT Research Enter Agreement on the Sublicensing of a Patent Related to a Diagnosing Method for Predicting Efficacy of Immune Checkpoint Inhibitors
- Advanced Medical Care Approval Received for Multiplex Gene Panel Testing to Advance Personalized Medicine
- Sysmex Formulates New Corporate Message:“Lighting the way with diagnostics”
-
Sysmex to Launch the Automated High-sensitive Immunoassay System for Research Applications HI-1000
-Promoting R&D on New Biomarkers Aimed at Achieving Personalized Medicine through Liquid Biopsy- -
Japan’s first-ever industry-academia alliance to realize the development of innovative medicine in Japan
Implementation of a one-stop bioresource project in Kyoto University, and the establishment of KBBM Co., Ltd. as a model of “industry-in-the-academia” industry-academia partnership -
Sysmex to Be Special Sponsor of the Kobe Marathon 2018
-We are pleased to have sponsored this exciting event since its inception in 2011- - Announcement of Organizational and Personnel Changes (PDF：182KB)
-
Sysmex Celebrates Its 50th Anniversary of Establishment
-Gratitude for All the Support over the Past 50 Years and a Commitment to Continue Taking on Challenges toward the Advancement of Healthcare- - FY2017 Nakatani Award and Research Grant Recipients Announced (PDF：117KB)
- Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2018 (PDF：347KB)
- Sysmex Harmony Co., Ltd., Certified as Special Subsidiary Company